Skip directly to content

eczema

What is happening with eczema innovation on the East Coast?

on Tue, 05/07/2013 - 7:43pm

Eczema doesn’t respect national borders. It’s something hundreds of millions of people around the world live with. As a patient and blogger I like to keep up with advances made around the world. I have my Google Alerts set up and other feeds open for information. At times it can seem like the world is flat and stuff is happening everywhere at once.

But is it true? Are research advances being made everywhere? The natural way for a reporter or blogger to proceed is to learn about hotspots of innovation and then pay attention to those hotspots.

Prevalence and Impact of Past History of Food Allergy in Atopic Dermatitis

Abstract
Background: Increases in allergic diseases have been reported from various epidemiological surveys. However, a few reports demonstrate the comorbidity of food allergy (FA) and allergic march. The aim of this study was to assess the prevalence and comorbidity of allergic diseases in Japanese students. Methods: First-year students (n = 3,321; 2,209 male and 1,112 female) at Osaka University were asked about allergic diseases using postal interview sheets.

Antibody therapy: an experimental eczema treatment

on Thu, 11/01/2012 - 10:40pm

For patients with extreme cases of eczema, a number of small trials worldwide hint at a possible future therapy.

Allergy tests for eczema a complex, controversial topic

on Tue, 09/04/2012 - 9:19pm

People with eczema—or parents of children with eczema—often suspect that food allergies are somehow setting off eczema flares. But nailing down exactly which foods cause trouble is made difficult by the many other factors that can trigger eczema. Such triggers include emotional or physical stress, environment, and viral or bacterial infection. Recently I spoke on the phone to Jon Hanifin, a professor of dermatology and clinician at Oregon Health Sciences University and NEA board member, to find out whether allergy tests can truly benefit eczema patients.

New Research Fuels Greater Understanding of Atopic Dermatitis and Psoriasis in Children and Adolescents

BOSTON (Aug. 16, 2012)  Information presented at American Academy of Dermatology’s Summer Academy Meeting by Lawrence F. Eichenfield, MD, FAAD, a board-certified pediatric dermatologist, chief, division of pediatric and adolescent dermatology and professor of pediatrics and medicine (dermatology), Rady Children’s Hospital and University of California, San Diego School of Medicine.  Dr. Eichenfield is also a member of the National Eczema Association Scientific Advisory Committee.

OVERVIEW
For the millions of children and adolescents affected by chronic skin conditions such as atopic

Novel smallpox vaccine should be safe for eczema patients

on Wed, 07/11/2012 - 8:10pm

The US government has ordered 20 million doses of a vaccine that should protect eczema patients from smallpox without exposing them to the risk of developing eczema vaccinatum, a life-threatening infection, according to a press release by the vaccine’s manufacturer, the Danish biotechnology company Bavarian Nordic.

This means that, in the event of a smallpox bioterror attack, instead of relying on the dubious security of herd immunity, people like you and me can get vaccinated. Until the advent of this new vaccine, we could not.

Eczema vaccinatum made the headlines in 2007 when an